(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics Hemostasis >  European Hemostasis Testing Market: Innovative Technologies and Emerging Business Opportunities

European Hemostasis Testing Market: Innovative Technologies and Emerging Business Opportunities



 

This unique report contains 500 pages, 120 tables and provides information not available from any other published source, including test and sales forecasts by market segment, as well as major reagent and instrument suppliers sales and market shares.

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next five years.  The report explores business and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next five years.  New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation.  Coagulation testing will also become more standardized, offering opportunities for quality control products and services.  Moreover, continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.                        

Contains 500 pages and 120 tables

To order sections of this report, contact Client Services


     
   
Local PDF: $18500.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X